Israel Health News API

{
    "totalArticles": 13848,
    "articles": [
        {
            "id": "15d1a04b2278cbf650cc8e48db9273d9",
            "title": "A new study: “Pink noise” may disrupt your sleep quality",
            "description": "A new study indicates that “pink noise,” used to improve sleep, may impair vital stages. The researchers warn of a possible effect on brain activity, especially among children.",
            "content": "A new study raises questions about the use of “pink noise” devices, which are common among those seeking to improve sleep quality. According to the study’s findings, sounds perceived as calming and sleep-promoting may negatively affect brain activity... [2231 chars]",
            "url": "https://www.jpost.com/health-and-wellness/sleep/article-888650",
            "image": "https://images.jpost.com/image/upload/f_auto,fl_lossy/q_auto/c_fill,g_faces:center,h_720,w_1280/709493",
            "publishedAt": "2026-03-03T15:00:00Z",
            "lang": "en",
            "source": {
                "id": "78834c45a26f98bca295cc641123cf7f",
                "name": "The Jerusalem Post",
                "url": "https://www.jpost.com"
            }
        },
        {
            "id": "b02474a22da0410c4425489d2061913e",
            "title": "Chronic Headaches Tied to Depression and Anxiety Risk",
            "description": "Find out more about how more than 40% of adults with chronic headache conditions experience depression or anxiety.",
            "content": "ADULTS with chronic headaches are nearly five times more likely to have depression and face more than seven times the risk of developing anxiety, a 2026 systematic review and meta-analysis has found.\nMore than 40% of adults with chronic headache cond... [2917 chars]",
            "url": "https://www.emjreviews.com/general-healthcare/news/chronic-headaches-tied-to-higher-rates-of-depression-and-anxiety/",
            "image": "https://www.emjreviews.com/wp-content/uploads/2026/03/headaches.jpg",
            "publishedAt": "2026-03-03T13:02:11Z",
            "lang": "en",
            "source": {
                "id": "a9f12901925fcfb02f9d57b5db396471",
                "name": "European Medical Journal",
                "url": "https://www.emjreviews.com"
            }
        },
        {
            "id": "91d4c107c5d6d93f6ac71eb01f8ea3d9",
            "title": "Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2026 MDA Clinical and Scientific Conference",
            "description": "/PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 2026...",
            "content": "BOULDER, Colo., March 3, 2026 /PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 2026 Muscular Dystrophy Association (MDA) Clinical and Scientific C... [4535 chars]",
            "url": "https://www.prnewswire.com/news-releases/edgewise-therapeutics-to-present-on-sevasemten-for-the-treatment-of-becker-muscular-dystrophy-at-the-2026-mda-clinical-and-scientific-conference-302701734.html",
            "image": "https://mma.prnewswire.com/media/2646316/Edgewise_Therapeutics_Logo.jpg?p=facebook",
            "publishedAt": "2026-03-03T13:00:00Z",
            "lang": "en",
            "source": {
                "id": "4e4307a07d2ce1e31acaf932954d3dd9",
                "name": "PR Newswire",
                "url": "https://www.prnewswire.com"
            }
        }
    ]
}